These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 8710376
1. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Wang H, Grand RJ, Milner AE, Armitage RJ, Gordon J, Gregory CD. Oncogene; 1996 Jul 18; 13(2):373-9. PubMed ID: 8710376 [Abstract] [Full Text] [Related]
2. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Walker A, Taylor ST, Hickman JA, Dive C. Cancer Res; 1997 May 15; 57(10):1939-45. PubMed ID: 9157989 [Abstract] [Full Text] [Related]
3. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Choi MS, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GG. Eur J Immunol; 1995 May 15; 25(5):1352-7. PubMed ID: 7539757 [Abstract] [Full Text] [Related]
4. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. Merino R, Grillot DA, Simonian PL, Muthukkumar S, Fanslow WC, Bondada S, Núñez G. J Immunol; 1995 Oct 15; 155(8):3830-8. PubMed ID: 7561089 [Abstract] [Full Text] [Related]
5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells. An S, Yap D, Knox KA. Cell Immunol; 1997 Nov 01; 181(2):139-52. PubMed ID: 9398401 [Abstract] [Full Text] [Related]
6. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation. Hsieh T, Wu JM. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1295-301. PubMed ID: 11027625 [Abstract] [Full Text] [Related]
7. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line. Padmore L, An S, Gunby RH, Kelly K, Radda GK, Knox KA. Cell Immunol; 1997 May 01; 177(2):119-28. PubMed ID: 9178638 [Abstract] [Full Text] [Related]
8. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells. An S, Park IC, Rhee CH, Hong SI, Knox K. Int J Oncol; 2003 Aug 01; 23(2):257-68. PubMed ID: 12851674 [Abstract] [Full Text] [Related]
9. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Pidgeon GP, Kandouz M, Meram A, Honn KV. Cancer Res; 2002 May 01; 62(9):2721-7. PubMed ID: 11980674 [Abstract] [Full Text] [Related]
10. Withdrawal of 2-mercaptoethanol induces apoptosis in a B-cell line via Fas upregulation. Neumann D, Zierke M, Martin MU. J Cell Physiol; 1998 Oct 01; 177(1):68-75. PubMed ID: 9731746 [Abstract] [Full Text] [Related]
11. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40. Kelly K, Knox KA. Cell Immunol; 1995 Nov 01; 166(1):93-102. PubMed ID: 7585986 [Abstract] [Full Text] [Related]
12. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan IC, Gregory CD, Gordon J. Eur J Immunol; 1993 Sep 01; 23(9):2368-71. PubMed ID: 8103750 [Abstract] [Full Text] [Related]
13. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Saltzman A, Munro R, Searfoss G, Franks C, Jaye M, Ivashchenko Y. Exp Cell Res; 1998 Jul 10; 242(1):244-54. PubMed ID: 9665822 [Abstract] [Full Text] [Related]
14. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM. Lin CK, Nguyen TT, Morgan TL, Mei RL, Kaptein JS, Kalunta CI, Yen CF, Park E, Zou HY, Lad PM. Exp Cell Res; 1998 Oct 10; 244(1):1-13. PubMed ID: 9770343 [Abstract] [Full Text] [Related]
15. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. Brown DM, Phipps RP. J Immunol; 1996 Aug 15; 157(4):1359-70. PubMed ID: 8759715 [Abstract] [Full Text] [Related]
16. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis. Alam MK, Davison S, Siddiqui N, Norton JD, Murphy JJ. Eur J Immunol; 1997 Dec 15; 27(12):3485-91. PubMed ID: 9464838 [Abstract] [Full Text] [Related]
17. Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line. Subramaniam PS, Cruz PE, Hobeika AC, Johnson HM. Oncogene; 1998 Apr 09; 16(14):1885-90. PubMed ID: 9583686 [Abstract] [Full Text] [Related]
18. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. Moreno MB, Memon SA, Zacharchuk CM. J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614 [Abstract] [Full Text] [Related]
19. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice. Truchet I, Jozan S, Guerrin M, Mazzolini L, Vidal S, Valette A. Exp Cell Res; 2000 Feb 01; 254(2):241-8. PubMed ID: 10640422 [Abstract] [Full Text] [Related]
20. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Christoffersen J, Smeland EB, Stokke T, Taskén K, Andersson KB, Blomhoff HK. Cancer Res; 1994 Apr 15; 54(8):2245-50. PubMed ID: 8174134 [Abstract] [Full Text] [Related] Page: [Next] [New Search]